I agree that this site is using cookies. You can find further informations here.
X
Cardin, Dana B.
154  results:
Search for persons X
?
1

First-in-human phase I/II, open-label study of the anti-OX4..:

Davis, Elizabeth J ; Martin-Liberal, Juan ; Kristeleit, Rebecca...
Journal for ImmunoTherapy of Cancer.  10 (2022)  10 - p. e004235 , 2022
Link: https://doi.org/10.1136/..
 
?
2

Safety and Efficacy of Avelumab in Small Bowel Adenocarcino..:

Cardin, Dana B. ; Gilbert, Jill ; Whisenant, Jennifer G....
Clinical Colorectal Cancer.  21 (2022)  3 - p. 236-243 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Pancreatic Cancer in Young Adults: Can Innovative Approache..:

Cardin, Dana B ; Eng, Cathy
JNCI: Journal of the National Cancer Institute.  113 (2021)  9 - p. 1125-1126 , 2021
Link: https://doi.org/10.1093/..
 
?
4

Clinical Activity and Safety of Cediranib and Olaparib Comb..:

Kim, Joseph W. ; Cardin, Dana B. ; Vaishampayan, Ulka N....
The Oncologist.  26 (2021)  7 - p. e1104-e1109 , 2021
Link: https://doi.org/10.1002/..
 
?
5

Recent advances in the treatment of pancreatic cancer:

Roth, Marc T ; Cardin, Dana B ; Berlin, Jordan D
F1000Research.  9 (2020)  - p. 131 , 2020
Link: https://doi.org/10.12688..
 
?
6

Immune-Related Adverse Events and Immune Checkpoint Inhibit..:

Das, Satya ; Ciombor, Kristen K. ; Haraldsdottir, Sigurdis...
The Oncologist.  25 (2020)  8 - p. 669-679 , 2020
Link: https://doi.org/10.1634/..
 
?
7

Advanced pancreatic cancer clinical trials: The continued u..:

White, Maya N. ; Dotan, Efrat ; Catalano, Paul J...
Journal of Geriatric Oncology.  10 (2019)  4 - p. 540-546 , 2019
Link: https://doi.org/10.1016/..
 
?
8

A phase 1b dose escalation study of Wnt pathway inhibitor v..:

Davis, S. Lindsey ; Cardin, Dana B. ; Shahda, Safi...
Investigational New Drugs.  38 (2019)  3 - p. 821-830 , 2019
Link: https://doi.org/10.1007/..
 
?
9

Could the PD-1 Pathway Be a Potential Target for Treating S..:

Thota, Ramya ; Gonzalez, Raul S ; Berlin, Jordan..
American Journal of Clinical Pathology.  148 (2017)  3 - p. 208-214 , 2017
Link: https://doi.org/10.1093/..
 
?
10

Phase II study of the Multikinase inhibitor of angiogenesis..:

Chan, Emily ; Goff, Laura W. ; Cardin, Dana B....
Investigational New Drugs.  35 (2017)  4 - p. 491-498 , 2017
Link: https://doi.org/10.1007/..
 
?
11

Dual Src and EGFR inhibition in combination with gemcitabin..:

Cardin, Dana B. ; Goff, Laura W. ; Chan, Emily...
Investigational New Drugs.  36 (2017)  3 - p. 442-450 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Phase I trial of vorinostat added to chemoradiation with ca..:

Chan, Emily ; Arlinghaus, Lori R. ; Cardin, Dana B....
Radiotherapy and Oncology.  119 (2016)  2 - p. 312-318 , 2016
Link: https://doi.org/10.1016/..
 
?
13

A phase I trial investigating pulsatile erlotinib in combin..:

Goff, Laura W. ; Cardin, Dana B. ; Whisenant, Jennifer G....
Investigational New Drugs.  35 (2016)  1 - p. 95-104 , 2016
Link: https://doi.org/10.1007/..
 
?
14

Phase II trial of sorafenib and erlotinib in advanced pancr..:

Cardin, Dana B. ; Goff, Laura ; Li, Chung‐I...
Cancer Medicine.  3 (2014)  3 - p. 572-579 , 2014
Link: https://doi.org/10.1002/..
 
?
15

Thymidylate Synthase Genotype-Directed Chemotherapy for Pat..:

Goff, Laura W. ; Thakkar, Nilay ; Du, Liping...
PLoS ONE.  9 (2014)  9 - p. e107424 , 2014
Link: https://doi.org/10.1371/..
 
1-15